Olga Saukh
ABSTRACT
Increasing popularity of inhaled therapy for the treatment of asthma and chronic obstructive pulmonary disease (COPD) stimulates research on both drug formulations and smart devices to support efficient pulmonary drug delivery. A major concern is the variability of the drug dose delivered to the lungs from the inhalation devices, due to the following three factors: 1) the drug formulation, 2) the device design, and 3) the patient's inhalation profile [23]. This paper investigates the use of microphones embedded in modern smartphones to accurately monitor the patient's inhalation manouvre. In our experiments we focus on dry powder inhalers (DPIs) with a breath-activated capsule spinning mechanism, such as Breezhaler®. We design an algorithm to capture inhalation profiles and evaluate it against measurements obtained with a precise gas flow meter. Our algorithm achieves an average error of up to 4.89 slm (standard liters per minute) given typical inspiratory flow rates through a Breezhaler® between 60 and 130 slm. We detect capsule rotation to ensure the inhalation was effective, and observe that the capsule spinning mechanism helps reduce measurement errors by 2 slm. Given a proper calibration, the proposed algorithm can be used with other capsule-based DPIs, such as HandiHaler®.
- P. Altman, L. Wehbe, J. Dederichs, and T. Guerin et. al. 2018. Comparison of peak inspiratory flow rate via the Breezhaler, Ellipta and HandiHaler dry powder inhalers in patients with moderate to very severe COPD. BMC Pulm Med. 18 (2018), 100.Google Scholar
Cross Ref
- M. Bonini and O. S. Usmani. 2015. The importance of inhaler devices in the treatment of COPD. COPD Research and Practice (2015), 1--9.Google Scholar
- P. Colthorpe, R. Pavkov, Y. Rozenman, and C. Humby. 2018. Adding Electronics to the Breezhaler: Satisfying the Needs of Patients and Regulators. Respiratory Drug Delivery 1 (2018), 71--80.Google Scholar
- P. Colthorpe, T. Voshaar, T. Kieckbusch, and E. Cuoghi et. al. 2013. Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium. J Drug Assess. 2(1) (2013), 11--6.Google ScholarCross Ref
- S. D'Arcy, E. MacHale, J. Seheult, and M. S. Holmes et. al. 2014. A Method to Assess Adherence in Inhaler Use through Analysis of Acoustic Recordings of Inhaler Events. PLOS 9(6) (2014).Google Scholar
- T. Van de Moortele, U. Goerke, C. H.Wendt, and F. Coletti. 2017. Airway morphology and inspiratory flow features in the early stages of Chronic Obstructive Pulmonary Disease. Clinical Biomech. (2017).Google Scholar
- J.J. Dederichs, D. Singh, and R. Pavkov. 2015. Inspiratory flow profiles generated by patients with COPD through the Breezhaler inhaler and other marketed dry powder inhalers. Am J Respir Crit Care Med, American Thoracic Society Int. Conf. 191 (2015).Google Scholar
- M. B. Dolovich, R. C. Ahrens, D. R. Hess, and P. Anderson et. al. 2005. Device selection and outcomes of aerosol therapy: Evidence-based guidelines. Chest. 127(1) (2005), 335--371.Google ScholarCross Ref
- T. Drugman, J. Urbain, N. Bauwens, and R. Chessini et. al. 2013. Objective Study of Sensor Relevance for Automatic Cough Detection. 17(3) (2013), 699--707.Google Scholar
- D. Enarson. 2013. Respiratory diseases in the world: Realities of today - opportunities for tomorrow. Int. Respiratory Societies (2013).Google Scholar
- US FDA Special Feature. 2016. Why You Need to Take Your Medications as Prescribed or Instructed.Google Scholar
- Su J. G., Barrett M. A., Henderson K., and Humblet O. et. al. 2017. Feasibility of Deploying Inhaler Sensors to Identify the Impacts of Environmental Triggers and Built Environment Factors on Asthma Short-Acting Bronchodilator Use. Env. Health Persp. 125(2) (2017), 254--261.Google ScholarCross Ref
- M. Gjoreski, M. Lustrek, M. Gams, and H. Gjoreski. 2017. Monitoring stress with a wrist device using context. 73 (2017), 159--170. Google ScholarDigital Library
- M. Goel, E. Saba, M. Stiber, and E. Whitmire et. al. 2016. SpiroCall: Measuring Lung Function over a Phone Call. In Proc. CHI Conf. on Human Factors in Computing Systems (CHI '16). 5675--5685. Google ScholarDigital Library
- C. Henderson. 2017. New Technologies for Low-Cost Connected Drug Delivery Devices. Connecting Drug Delivery 76 (2017), 5--9.Google Scholar
- D. Hira, H. Koide, S. Nakamura, and T. Okada et. al. 2018. Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices. 13 (2018), e0193082.Google Scholar
- M. Hoppentocht, P. Hagedoorn, H.W. Frijlink, and A.H. de Boer. 2014. Technological and practical challenges of dry powder inhalers and formulations. 75 (2014), 18--31.Google Scholar
- M. Ibrahim, R. Verma, and L. Garcia-Contreras. 2015. Inhalation drug delivery devices: technology update. Med Devices 8 (2015), 131--139.Google Scholar
- A. Kuttler and T. Dimke. 2014. A novel biophysical simulation model of drug deposition implemented to predict and optimize QVA149 delivery to the lungs. In American Thoracic Society Int. Conf.Google Scholar
- N. R. Labiris and M. B. Dolovich. 2003. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 56(6) (2003), 600--12.Google ScholarCross Ref
- B.L. Laube, H.M. Janssens, F.H.C. de Jongh, and S.G. Devadason et. al. 2011. What the pulmonary specialist should know about the new inhalation therapies. European Respiratory J. 37 (2011), 1308--1417.Google ScholarCross Ref
- F. Lavorini, C. Mannini, E. Chellini, and G. A. Fontana. 2016. Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices. Drugs Aging 33(7) (2016), 461--473.Google ScholarCross Ref
- F. Lavorini, M. Pistolesi, and O. S. Usmani. 2017. Recent advances in capsule-based dry powder inhaler technology. 12 (2017), 19.Google Scholar
- K. M. Lim, S. M. Lee, D. Harris, and P. Seeney. 2018. Robust Characterization of Inhalation Information Using a Deep Neural Network and Smartphone. 2 (2018), 477--480.Google Scholar
- S. Magzamen, A. P. Oron, E. R. Locke, and V. S. Fan. 2018. Association of ambient pollution with inhaler use among patients with COPD: A panel study. Occupational and Env. Medicine 75 (2018), 382--388.Google ScholarCross Ref
- M. Molimard, C. Raherison, S. Lignot, and A. Balestra et. al. 2017. Chronic obstructive pulmonary disease exacerbation and inhaler device handling. Eur Respir J. 49(2) (2017).Google Scholar
- S. Mueller and B. S. E. Haeberlin. 2008. Comparison of performance characteristics for Foradil Aerolizer and Foradil Concept1 (a new single dose dry powder inhaler) at different test flow rates. Resp Drug Deliv. 3 (2008), 67--678.Google Scholar
- C. Mulcahy. 2017. Smart Drug Delivery: Pragramic approach reduces risk, increases innovation and patient adherence. On Drug Delivery Magazine 76 (2017), 62--66.Google Scholar
- T. Oakley. 2018. Connected Drug Delivery Sector Overview. On Drug Delivery Magazine 87 (2018), 4--8.Google Scholar
- S. Pascual, J. Feimer, A. Soyza, and J. Sauleda et. al. 2015. Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: A randomised, cross-over, multicentre study. NPJ Primary Care Respiratory Medicine 25 (04 2015), 15018.Google Scholar
- R. Pavkov and D. Singh. 2008. Concept1 (a new single dose dry powder inhaler) peak inspiratory flow rate study with COPD patients. Resp Drug Deliv. 3 (2008), 683--686.Google Scholar
- D. Prime, W. de Backer, M. Hamilton, and A. Cahn et. al. 2015. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA Dry Powder Inhaler. Journal Aerosol Med Pulm Drug Deliv. 28(6) (2015), 486--497.Google ScholarCross Ref
- D. Van Sickle, S. Magzamen, S. Truelove, and T. Morrison. 2013. Remote Monitoring of Inhaled Bronchodilator Use and Weekly Feedback about Asthma Management: An Open-Group, Short-Term Pilot Study of the Impacton Asthma Control. PLOS (2013).Google Scholar
- J. van der Palen, M. Thomas, H. Chrystyn, and R. K Sharma et. al. 2016. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices. NPJ Prim Care Respir Med. 26 (2016).Google Scholar
Index Terms
- Capturing Inhalation Efficiency with Acoustic Sensors in Mobile Phones
Recommendations
Facilitating medication adherence and eliminating therapeutic inertia using wireless technology: proof of concept findings with uncontrolled hypertensives and kidney transplant recipients
WH '12: Proceedings of the conference on Wireless HealthEffective and efficient management of chronic illness remains a significant clinical problem. To improve chronic illness management, two obstacles that must be overcome are patient non-adherence to medication regimens and provider therapeutic inertia (...
A Mobile Health System to Identify the Onset of Paroxysmal Atrial Fibrillation
ICHI '15: Proceedings of the 2015 International Conference on Healthcare InformaticsAtrial Fibrillation (AFib) is increasingly recognized as a risk factor for clots, strokes, heart failure and other complications. One estimate states that 2.7 million individuals are living in U.S. With AFib and this number may increase to 5.6 million ...
Type 2 Diabetes Patients Benefit from the COMODITY12 mHealth System: Results of a Randomised Trial
Patient acceptance is one of the major barriers toward widespread use of mHealth systems. The aim of this study was to assess system operability and whole trial feasibility, including patients' experience with their use of COMMODITY12 mHealth system ...
Comments